{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:21:38Z","timestamp":1790785298238,"version":"4.1.0"},"reference-count":374,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00291","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:14:16Z","timestamp":1554250456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":118,"title":["Biomarkers in Motor Neuron Disease: A State of the Art Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Nick S.","family":"Verber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie R.","family":"Shepheard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Sassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry E.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J. P.","family":"Alix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain D.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.pmr.2008.04.002","article-title":"Cognitive and behavioral impairment in amyotrophic lateral sclerosis","volume":"19","author":"Woolley","year":"2008","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/17482968.2010.495158","article-title":"Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)\u2013a 20-year review: can we do better?","volume":"11","author":"Mitchell","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40478-015-0226-y","article-title":"Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways","volume":"3","author":"Fatima","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP-43 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Ann Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu090","article-title":"Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathology","author":"Kassubek","year":"2014","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/jnnp-2011-301826","article-title":"Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation?","volume":"83","author":"Kanouchi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2013.778548","article-title":"Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis","author":"Ravits","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.celrep.2016.09.032","article-title":"Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS\/FTD","volume":"17","author":"Westergard","year":"2016","journal-title":"Cell Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.neuro.2012.02.015","article-title":"Interrelationships of undernutrition and neurotoxicity: food for thought and research attention","volume":"33","author":"Spencer","year":"2012","journal-title":"Neurotoxicology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","article-title":"Nutritional status is a prognostic factor for survival in ALS patients","volume":"53","author":"Desport","year":"1999","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp.2010.211474","article-title":"Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients","volume":"82","author":"Marin","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","article-title":"Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial","volume":"5","author":"Bourke","year":"2006","journal-title":"Lancet Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"PA3730","DOI":"10.1183\/13993003.congress-2015.PA3730","article-title":"Measurement of vital capacity in amyotrophic lateral sclerosis \u2013 forced and slowly performed","volume":"46","author":"Andersen","year":"2015","journal-title":"Eur Resp J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/jnnp.2005.072660","article-title":"Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population","volume":"77","author":"Czaplinski","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1164\/rccm.201604-0848OC","article-title":"Respiratory muscle strength as a predictive biomarker for survival in amyotrophic lateral sclerosis","volume":"195","author":"Polkey","year":"2017","journal-title":"Am J Resp Crit Care Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12931-017-0624-8","article-title":"The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis","volume":"18","author":"Tilanus","year":"2017","journal-title":"Respir Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00415-014-7613-3","article-title":"Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis","volume":"262","author":"Capozzo","year":"2015","journal-title":"J Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1164\/ajrccm.162.4.9910034","article-title":"Usefulness of sniff nasal pressure in patients with neuromuscular or skeletal disorders","volume":"162","author":"Stefanutti","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1034\/j.1399-3003.2000.15.18.x","article-title":"Sniff nasal inspiratory pressure as a marker of respiratory function in motor neuron disease","volume":"15","author":"Chaudri","year":"2000","journal-title":"Eur Respir J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/21678421.2015.1112406","article-title":"Phrenic nerve conduction studies as a biomarker of respiratory insufficiency in amyotrophic lateral sclerosis","volume":"17","author":"Jenkins","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.smrv.2015.05.007","article-title":"Sleep disorders and respiratory function in amyotrophic lateral sclerosis","volume":"26","author":"Ahmed","year":"2016","journal-title":"Sleep Med Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000447560","article-title":"The prognostic role of obstructive sleep apnea at the onset of amyotrophic lateral sclerosis","volume":"17","author":"Quaranta","year":"2017","journal-title":"Neurodegen Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","article-title":"Anatomy and physiology of cerebrospinal fluid","volume":"128","author":"Sakka","year":"2011","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J Neurochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00290","article-title":"Neurofilaments in CSF as diagnostic biomarkers in motor neuron disease: a meta-analysis","author":"Li","year":"","journal-title":"Front Aging Neurosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jnnp-2015-311387","article-title":"Neurofilaments in the diagnosis of Moto neuron diseases: a prospective study on 455 patients","volume":"87","author":"Steinacker","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Posen","year":"2017","journal-title":"Neurology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","article-title":"Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS","volume":"17","author":"Oeckl","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/21678421.2012.729596","article-title":"pNfH is a promising biomarker for ALS","volume":"14","author":"Ganesalingam","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/21678421.2014.884592","article-title":"Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis","volume":"15","author":"Lehnert","year":"2014","journal-title":"Amyotrop Lateral Scler Frontotemporal Degener"},{"key":"B32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/21678421.2017.1281962","article-title":"Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival","volume":"18","author":"Skillb\u00e4ck","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","article-title":"Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression","volume":"19","author":"Tortelli","year":"2012","journal-title":"Eur J Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0164625","DOI":"10.1371\/journal.pone.0164625","article-title":"Neurofilaments as biomarkers for amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000478979","article-title":"Cerebrospinal fluid TAR DNA-binding protein 43 combined with tau proteins as a candidate biomarker for amyotrophic lateral sclerosis and frontotemporal dementia spectrum disorders","volume":"44","author":"Bourbouli","year":"2017","journal-title":"Dementia Geriatr Cogn Disord"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.neurobiolaging.2014.10.019","article-title":"Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis","volume":"36","author":"Wilke","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1468-1331.2008.02405.x","article-title":"Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis","volume":"16","author":"Paladino","year":"2009","journal-title":"Eur J Neurol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/archneur.65.11.1481","article-title":"TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"65","author":"Steinacker","year":"2008","journal-title":"Arch Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00401-008-0456-1","article-title":"Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"117","author":"Kasai","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/17482968.2010.541263","article-title":"Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value","volume":"12","author":"Noto","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"B45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000444788","article-title":"Cerebrospinal fluid TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis patients with and without the C9ORF72 hexanucleotide expansion","volume":"6","author":"Junttila","year":"2016","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"B46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3109\/21678421.2014.905606","article-title":"Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases","volume":"15","author":"Feneberg","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/prca.201200067","article-title":"Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery","volume":"7","author":"Kr\u00fcger","year":"2013","journal-title":"Proteomics Clin Appl"},{"key":"B48","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/14789450.2017.1365602","article-title":"Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Barschke","year":"2017","journal-title":"Exp Rev Proteomics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1021\/acs.jproteome.5b00804","article-title":"Label-Free LC-MS\/MS proteomic analysis of cerebrospinal fluid identifies protein\/pathway alterations and candidate biomarkers for amyotrophic lateral sclerosis","volume":"14","author":"Collins","year":"2015","journal-title":"J Proteome Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12883-016-0689-x","article-title":"Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Neurol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e15133","DOI":"10.1371\/journal.pone.0015133","article-title":"Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis","volume":"5","author":"Wilson","year":"2010","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/mus.21683","article-title":"Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics","volume":"42","author":"Ryberg","year":"2010","journal-title":"Muscle Nerve"},{"key":"B53","first-page":"5419","article-title":"Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"8","author":"Ren","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1559-0275-10-19","article-title":"Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis","volume":"10","author":"Varghese","year":"2013","journal-title":"Clin Proteomics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3892\/etm.2016.3210","article-title":"Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis","volume":"11","author":"Chen","year":"2016","journal-title":"Exp Ther Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1136\/jnnp-2017-317138","article-title":"Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression","volume":"89","author":"Steinacker","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.25143","article-title":"Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis","volume":"83","author":"Thompson","year":"2018","journal-title":"Ann Neurol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e13223","DOI":"10.1371\/annotation\/2c2f8fce-a5be-40a3-af8f-48f119b2c593","article-title":"H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis","volume":"5","author":"Blasco","year":"2010","journal-title":"PLoS ONE"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1212\/WNL.0000000000000274","article-title":"Untargeted 1H-NMR metabolomics in CSF","volume":"82","author":"Blasco","year":"2014","journal-title":"Neurology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"17652","DOI":"10.1038\/s41598-017-17389-9","article-title":"Lipidomics reveals cerebrospinal-fluid signatures of ALS","volume":"7","author":"Blasco","year":"2017","journal-title":"Sci Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/ene.12956","article-title":"Metabolomics in amyotrophic lateral sclerosis: how far can it take us?","volume":"23","author":"Blasco","year":"2016","journal-title":"Eur J Neurol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cca.2010.01.016","article-title":"Metabolomic analysis of serum by, H NMR spectroscopy in amyotrophic lateral sclerosis","volume":"411","author":"Kumar","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11306-005-4810-1","article-title":"Metabolomic analysis and signatures in motor neuron disease","volume":"1","author":"Rozen","year":"2005","journal-title":"Metabolomics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.freeradbiomed.2013.06.029","article-title":"Clinical perspective of oxidative stress in sporadic amyotrophic lateral sclerosis","volume":"65","author":"D'Amico","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/00002281-200311000-00008","article-title":"Oxidative stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis","volume":"15","author":"Simpson","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.21543","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"Rothstein","year":"2009","journal-title":"Ann Neurol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1471-4159.2011.07177.x","article-title":"Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients","volume":"117","author":"Zetterstrom","year":"2011","journal-title":"J Neurochem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamaneurol.2013.593","article-title":"SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy","volume":"70","author":"Winer","year":"2013","journal-title":"JAMA Neurol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"A Phase I, randomised, first-in-human study of an antisense oligonucleotide directed against SOD1 delivered intrathecally in SOD1-familial ALS patients","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/jnnp-2016-313521","article-title":"Defining SOD1 ALS natural history to guide therapeutic clinical trial design","volume":"88","author":"Bali","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/17482960801933942","article-title":"Oxidative stress biomarkers in sporadic ALS","volume":"9","author":"Mitsumoto","year":"2008","journal-title":"Amyotroph Lateral Scler."},{"key":"B73","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ana.410420416","article-title":"Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis","volume":"42","author":"Beal","year":"1997","journal-title":"Ann Neurol."},{"key":"B74","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0891-5849(00)00349-X","article-title":"Increased oxidative damage to DNA in ALS patients","volume":"29","author":"Bogdanov","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2015.07.147","article-title":"Nrf2 -a therapeutic target for the treatment of neurodegenerative diseases","author":"Johnson","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.freeradbiomed.2013.04.018","article-title":"S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis","volume":"61","author":"Mead","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12974-015-0350-4","article-title":"Humoral factors in ALS patients during disease progression","volume":"12","author":"Ehrhart","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B79","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00415-006-0301-1","article-title":"Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis","volume":"254","author":"Siciliano","year":"2007","journal-title":"J Neurol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1089\/ars.2017.7433","article-title":"Can oxidation-reduction potential of cerebrospinal fluid be a monitoring biomarker in amyotrophic lateral sclerosis?","volume":"28","author":"Opacic","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"B81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/intimm\/dxu099","article-title":"Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective","volume":"27","author":"Malaspina","year":"2015","journal-title":"Int Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis","volume":"72","author":"Mitchell","year":"2009","journal-title":"Neurology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e00637","DOI":"10.1002\/brb3.637","article-title":"Evaluating the levels of CSF and serum factors in ALS","volume":"7","author":"Guo","year":"2017","journal-title":"Brain Behav."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0149821","DOI":"10.1371\/journal.pone.0149821","article-title":"A multiplex protein panel applied to cerebrospinal fluid reveals three new biomarker candidates in ALS but none in neuropathic pain patients","volume":"11","author":"Lind","year":"2016","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/21678421.2014.984723","article-title":"Serum ferritin is elevated in amyotrophic lateral sclerosis patients","volume":"16","author":"Su","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0136937","DOI":"10.1145\/2818302","article-title":"Elevated levels of IFN-\u03b3 in CSF and serum of patients with amyotrophic lateral sclerosis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu120","article-title":"Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions","author":"Cooper-Knock","year":"2014","journal-title":"Brain"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron."},{"key":"B89","doi-asserted-by":"publisher","first-page":"859","DOI":"10.15252\/emmm.201607486","article-title":"Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS\/FTD","volume":"9","author":"Lehmer","year":"2017","journal-title":"EMBO Mol Med."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis","author":"Gendron","year":"","journal-title":"Sci Transl Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00731","article-title":"Small RNA sequencing of sporadic amyotrophic lateral sclerosis cerebrospinal fluid reveals differentially expressed miRNAs related to neural and glial activity","author":"Waller","year":"","journal-title":"Front Neurosci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/2051-5960-1-42","article-title":"Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis","volume":"1","author":"Freischmidt","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"B93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10048-014-0420-2","article-title":"miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients","volume":"15","author":"De","year":"2014","journal-title":"Neurogenetics"},{"key":"B94","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s12017-016-8396-8","article-title":"Identification of miRNAs as Potential biomarkers in cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"18","author":"Benigni","year":"2016","journal-title":"Neuromol Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1212\/WNL.48.1.55","article-title":"Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu,Zn superoxide dismutase","volume":"48","author":"Juneja","year":"1997","journal-title":"Neurology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/21678421.2016.1213852","article-title":"Rare genetic variation in UNC13A may modify survival in amyotrophic lateral sclerosis","volume":"17","author":"Gaastra","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B97","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","article-title":"Gene discovery in amyotrophic lateral sclerosis: implications for clinical management","volume":"13","author":"Al-Chalabi","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ana.24950","article-title":"Pyrimethamine significantly lowers cerebrospinal fluid Cu\/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations","volume":"81","author":"Lange","year":"2017","journal-title":"Ann Neurol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/17482968.2012.724074","article-title":"Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot study","volume":"14","author":"Lange","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e75916","DOI":"10.1371\/journal.pone.0075916","article-title":"Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis","volume":"8","author":"Cereda","year":"2013","journal-title":"PLoS ONE"},{"key":"B101","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-010-0786-7","article-title":"Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations","volume":"121","author":"De","year":"2011","journal-title":"Acta Neuropathol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e25545","DOI":"10.1371\/journal.pone.0025545","article-title":"Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells","volume":"6","author":"Nardo","year":"2011","journal-title":"PLoS ONE"},{"key":"B103","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/17482968.2012.703208","article-title":"TDP-43 plasma levels are higher in amyotrophic lateral sclerosis","volume":"13","author":"Verstraete","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"B104","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40572-015-0050-3","article-title":"DNA methylation in whole blood: uses and challenges","volume":"2","author":"Houseman","year":"2015","journal-title":"Curr Environ Health Rep"},{"key":"B105","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/21678421.2013.851247","article-title":"Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset","volume":"15","author":"Tremolizzo","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B106","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/21678421.2017.1367401","article-title":"Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations","volume":"19","author":"Copped\u00e8","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B107","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/mgg3.302","article-title":"Whole exome sequencing and DNA methylation analysis in a clinical amyotrophic lateral sclerosis cohort","volume":"5","author":"Garton","year":"2017","journal-title":"Mol Genet Genomic Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/jamaneurol.2016.1114","article-title":"Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis","volume":"73","author":"Fogh","year":"2016","journal-title":"JAMA Neurol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00401-015-1401-8","article-title":"The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients","volume":"129","author":"Xi","year":"2015","journal-title":"Acta Neuropathol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-014-1286-y","article-title":"C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS\/FTD","volume":"128","author":"Liu","year":"2014","journal-title":"Acta Neuropathol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/mp.2015.159","article-title":"The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter","volume":"21","author":"Gijselinck","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B112","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jns.2014.12.004","article-title":"Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis","volume":"348","author":"Liu","year":"2015","journal-title":"J Neurol Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0182638","article-title":"Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis","volume":"12","author":"Young","year":"2017","journal-title":"PLoS ONE"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","article-title":"Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis","volume":"90","author":"Feneberg","year":"2018","journal-title":"Neurology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"J Neurochem."},{"key":"B116","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B117","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","article-title":"Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS","volume":"126","author":"Gendron","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jns.2015.04.032","article-title":"Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis","volume":"353","author":"McCombe","year":"2015","journal-title":"J Neurol Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e0182002","DOI":"10.1371\/journal.pone.0182002","article-title":"Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis","volume":"12","author":"Gustafson","year":"2017","journal-title":"PLoS ONE"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","article-title":"Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression","volume":"74","author":"Murdock","year":"2017","journal-title":"JAMA Neurol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/emmm.201201544","article-title":"Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival","volume":"5","author":"Henkel","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1212\/NXI.0000000000000244","article-title":"Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis","volume":"3","author":"Lu","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B124","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0304-3940(00)01177-0","article-title":"Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis","volume":"287","author":"Poloni","year":"2000","journal-title":"Neurosci Lett"},{"key":"B125","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneuroim.2007.10.028","article-title":"TNF and sTNFR1\/2 plasma levels in ALS patients","volume":"194","author":"Cereda","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1017\/cjn.2016.284","article-title":"Panel of oxidative stress and inflammatory biomarkers in ALS: a Pilot Study","volume":"44","author":"Blasco","year":"2017","journal-title":"Can J Neurol Sci"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11064-007-9564-x","article-title":"Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India","volume":"33","author":"Babu","year":"2008","journal-title":"Neurochem Res"},{"key":"B128","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","article-title":"Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.bbrc.2006.02.051","article-title":"Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease","volume":"342","author":"Goldknopf","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B130","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/21678421.2018.1433689","article-title":"Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects","volume":"19","author":"Xu","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B131","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"32478","DOI":"10.1038\/srep32478","article-title":"Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China","volume":"6","author":"Hou","year":"2016","journal-title":"Sci Rep"},{"key":"B133","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1038\/s41598-017-04706-5","article-title":"Adipokines, C-reactive protein and amyotrophic lateral sclerosis - results from a population- based ALS registry in Germany","volume":"7","author":"Nagel","year":"2017","journal-title":"Sci Rep"},{"key":"B134","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamaneurol.2016.6179","article-title":"Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis","volume":"74","author":"Lunetta","year":"2017","journal-title":"JAMA Neurol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jns.2014.12.016","article-title":"Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study","volume":"348","author":"Pagliardini","year":"2015","journal-title":"J Neurol Sci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/ene.12754","article-title":"Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis","volume":"22","author":"Patin","year":"2015","journal-title":"Eur J Neurol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","article-title":"Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study","volume":"71","author":"Chi\u00f2","year":"2014","journal-title":"JAMA Neurol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/21678421.2014.943672","article-title":"A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS","volume":"15","author":"Bozik","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2169\/internalmedicine.51.7465","article-title":"Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study","volume":"51","author":"Ikeda","year":"2012","journal-title":"Intern Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/ene.12995","article-title":"Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis","volume":"23","author":"Rafiq","year":"2016","journal-title":"Eur J Neurol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/jnnp-2017-317077","article-title":"Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials","volume":"89","author":"van","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B142","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fneur.2017.00322","article-title":"Correlation of creatine kinase levels with clinical features and survival in amyotrophic lateral sclerosis","volume":"8","author":"Tai","year":"2017","journal-title":"Front Neurol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e0174925","DOI":"10.1371\/journal.pone.0174925","article-title":"Predicting functional decline and survival in amyotrophic lateral sclerosis","volume":"12","author":"Ong","year":"2017","journal-title":"PLoS ONE"},{"key":"B144","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.gene.2012.07.058","article-title":"A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis","volume":"508","author":"De","year":"2012","journal-title":"Gene"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu249","article-title":"Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers","author":"Freischmidt","year":"2014","journal-title":"Brain"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.neurobiolaging.2015.06.003","article-title":"Serum microRNAs in sporadic amyotrophic lateral sclerosis","volume":"36","author":"Freischmidt","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e89065","DOI":"10.1371\/journal.pone.0089065","article-title":"MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis","volume":"9","author":"Toivonen","year":"2014","journal-title":"PLoS ONE"},{"key":"B148","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2017.03.027","article-title":"Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)","volume":"55","author":"Waller","year":"2017","journal-title":"Neurobiol Aging"},{"key":"B149","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mus.26106","article-title":"Correlating serum microRNAs and clinical parameters in Amyotrophic lateral sclerosis","volume":"58","author":"Raheja","year":"2018","journal-title":"Muscle Nerve"},{"key":"B150","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2016.06.046","article-title":"MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis","volume":"368","author":"de","year":"2016","journal-title":"J Neurol Sci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13041-015-0161-7","article-title":"Identification of plasma microRNAs as a biomarker of sporadic amyotrophic lateral sclerosis","volume":"8","author":"Takahashi","year":"2015","journal-title":"Mol Brain"},{"key":"B152","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","article-title":"Blood biomarkers of carbohydrate, lipid and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20 year follow-up of the Swedish AMORIS cohort","volume":"81","author":"Mariosa","year":"2017","journal-title":"Ann Neurol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/21678421.2014.920032","article-title":"Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis","volume":"15","author":"Cecchi","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"B154","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/21678421.2014.908311","article-title":"Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics","volume":"15","author":"Lawton","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B155","first-page":"137","article-title":"Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis","volume":"22","author":"Andreadou","year":"2008","journal-title":"In Vivo"},{"key":"B156","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.clineuro.2007.10.018","article-title":"Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment","volume":"110","author":"Andreadou","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"B157","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1034\/j.1600-0404.2002.00206.x","article-title":"Effect of Riluzole on serum amino acids in patients with amyotrophic lateral sclerosis","volume":"106","author":"Niebroj-Dobosz","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"B158","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/17482960801934239","article-title":"Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis","volume":"9","author":"Palma","year":"2008","journal-title":"Amyotroph Lateral Scler"},{"key":"B159","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/17482968.2011.619197","article-title":"Biochemical alterations associated with ALS","volume":"13","author":"Lawton","year":"2012","journal-title":"Amyotroph Lateral Scler."},{"key":"B160","doi-asserted-by":"publisher","first-page":"e79733","DOI":"10.1371\/journal.pone.0079733","article-title":"Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling","volume":"8","author":"Conraux","year":"2013","journal-title":"PLoS ONE"},{"key":"B161","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/C5MB00711A","article-title":"Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects","volume":"12","author":"Wuolikainen","year":"2016","journal-title":"Mol BioSyst"},{"key":"B162","doi-asserted-by":"publisher","first-page":"e45034","DOI":"10.1371\/journal.pone.0045034","article-title":"Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis","volume":"7","author":"Nadjar","year":"2012","journal-title":"PLoS ONE"},{"key":"B163","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2009.06.002","article-title":"Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress?","volume":"285","author":"Keizman","year":"2009","journal-title":"J Neurol Sci"},{"key":"B164","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3988\/jcn.2015.11.4.376","article-title":"Prognostic role of serum levels of uric acid in amyotrophic lateral sclerosis","volume":"11","author":"Oh","year":"2015","journal-title":"J Clin Neurol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11011-014-9510-y","article-title":"Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population","volume":"29","author":"Zheng","year":"2014","journal-title":"Metabol Brain Dis"},{"key":"B166","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00415-010-5735-9","article-title":"An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis","volume":"258","author":"Zoccolella","year":"2011","journal-title":"J Neurol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/21678421.2017.1418005","article-title":"Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis","volume":"19","author":"O'Reilly","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00415-012-6440-7","article-title":"Uric acid levels predict survival in men with amyotrophic lateral sclerosis","volume":"259","author":"Paganoni","year":"2012","journal-title":"J Neurol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mus.25950","article-title":"Urate levels predict survival in amyotrophic lateral sclerosis: analysis of the expanded Pooled Resource Open-Access ALS clinical trials database","volume":"57","author":"Paganoni","year":"2018","journal-title":"Muscle Nerve"},{"key":"B170","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jns.2015.10.023","article-title":"Level of neurotoxic metals in amyotrophic lateral sclerosis: a population-based case-control study","volume":"359","author":"Bocca","year":"2015","journal-title":"J Neurol Sci"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s10072-017-3018-2","article-title":"Essential trace elements in amyotrophic lateral sclerosis (ALS): results in a population of a risk area of Italy","volume":"38","author":"Forte","year":"2017","journal-title":"Neurol Sci"},{"key":"B172","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.chemosphere.2018.01.076","article-title":"Trace elements in ALS patients and their relationships with clinical severity","volume":"197","author":"Oggiano","year":"2018","journal-title":"Chemosphere"},{"key":"B173","doi-asserted-by":"publisher","first-page":"9800","DOI":"10.1074\/jbc.270.17.9800","article-title":"Cyclooxygenase-dependent formation of the isoprostane","volume":"270","author":"Pratico","year":"1995","journal-title":"J Biol Chem"},{"key":"B174","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1600-0404.1999.tb01048.x","article-title":"Decreased urinary concentrations of type IV collagen in amyotrophic lateral sclerosis","volume":"100","author":"Ono","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"B175","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/mus.1075","article-title":"Urinary collagen metabolite excretion in amyotrophic lateral sclerosis","volume":"24","author":"Ono","year":"2001","journal-title":"Muscle Nerve"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e87398","DOI":"10.1371\/journal.pone.0087398","article-title":"The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis","volume":"9","author":"Shepheard","year":"2014","journal-title":"PLoS ONE"},{"key":"B177","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41598-017-05430-w","article-title":"Urinary extracellular domain of neurotrophin receptor p75 as a biomarker for amyotrophic lateral sclerosis in a Chinese cohort","volume":"7","author":"Jia","year":"2017","journal-title":"Sci Rep"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1212\/WNL.0000000000003741","article-title":"Urinary p75(ECD): a prognostic, disease progression, and pharmacodynamic biomarker in ALS","volume":"88","author":"Shepheard","year":"2017","journal-title":"Neurology."},{"key":"B179","first-page":"90","article-title":"Chapter 5: magnetic resonance imaging","volume-title":"Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging","author":"Wilkinson","year":"2014"},{"key":"B180","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s002340000472","article-title":"Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis","volume":"43","author":"Sarchielli","year":"2001","journal-title":"Neuroradiology"},{"key":"B181","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-2377-6-17","article-title":"Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis","volume":"6","author":"Grosskreutz","year":"2006","journal-title":"BMC Neurol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"e80748","DOI":"10.1371\/journal.pone.0080748","article-title":"Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis","volume":"8","author":"Mezzapesa","year":"2013","journal-title":"PLoS ONE"},{"key":"B183","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.compmedimag.2005.10.001","article-title":"Fuzzy c-means clustering with spatial information for image segmentation","volume":"30","author":"Chuang","year":"2006","journal-title":"Comput Med Imaging Graph"},{"key":"B184","doi-asserted-by":"publisher","first-page":"473250","DOI":"10.1155\/2014\/473250","article-title":"Side of limb-onset predicts laterality of gray matter loss in amyotrophic lateral sclerosis","volume":"2014","author":"Zhang","year":"2014","journal-title":"Biomed Res Int"},{"key":"B185","first-page":"255","article-title":"Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis","volume":"28","author":"Mezzapesa","year":"2007","journal-title":"Am J Neuroradiol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.neurobiolaging.2014.09.002","article-title":"Subcortical structures in amyotrophic lateral sclerosis","volume":"36","author":"Westeneng","year":"2015","journal-title":"Neurobiol Aging"},{"key":"B187","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2377-6-48","article-title":"Amygdala size in amyotrophic lateral sclerosis without dementia: an in vivo study using MRI volumetry","volume":"6","author":"Pinkhardt","year":"2006","journal-title":"BMC Neurol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1136\/jnnp.2006.101758","article-title":"Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability","volume":"78","author":"Thivard","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B189","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nicl.2017.01.024","article-title":"Longitudinal evaluation of cerebral and spinal cord damage in amyotrophic lateral sclerosis","volume":"14","author":"de","year":"2017","journal-title":"Neuroimage Clin"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/s41598-018-19938-2","article-title":"MRI of the cervical spinal cord predicts respiratory dysfunction in ALS","volume":"8","author":"Grolez","year":"2018","journal-title":"Sci Rep."},{"key":"B191","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/jnnp-2013-306839","article-title":"Cortical thickness in ALS: towards a marker for upper motor neuron involvement","volume":"86","author":"Walhout","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B192","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00415-005-0646-x","article-title":"Frontotemporal white matter changes in amyotrophic lateral sclerosis","volume":"252","author":"Abrahams","year":"2005","journal-title":"J Neurol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neurobiolaging.2017.09.019","article-title":"Multimodal MRI quantification of the common neurostructural bases within the FTD-ALS continuum","volume":"62","author":"Crespi","year":"2018","journal-title":"Neurobiol Aging"},{"key":"B194","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1212\/WNL.57.9.1571","article-title":"Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS","volume":"57","author":"Ellis","year":"2001","journal-title":"Neurology."},{"key":"B195","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14660820510038538","article-title":"Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI","volume":"6","author":"Kassubek","year":"2005","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord."},{"key":"B196","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jmri.24582","article-title":"Histological-MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis","volume":"41","author":"Meadowcroft","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"B197","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1148\/radiol.2018162967","article-title":"MR imaging-based estimation of upper motor neuron density in patients with amyotrophic lateral sclerosis: a feasibility study","volume":"287","author":"Chen","year":"2018","journal-title":"Radiology"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.02951.x","article-title":"EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases","author":"Filippi","year":"2010","journal-title":"Eur J Neurol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/17482960902777339","article-title":"Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study","volume":"10","author":"Charil","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"B200","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0022-510X(01)00503-2","article-title":"MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images","volume":"186","author":"Hecht","year":"2001","journal-title":"J Neurol Sci"},{"key":"B201","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s002340050836","article-title":"MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis","volume":"41","author":"Peretti-Viton","year":"1999","journal-title":"Neuroradiology"},{"key":"B202","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jon199774208","article-title":"Degeneration of the pyramidal tracts in patients with amyotrophic lateral sclerosis. A premortem and postmortem magnetic resonance imaging study","volume":"7","author":"Abe","year":"1997","journal-title":"J Neuroimaging."},{"key":"B203","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1148\/radiology.172.2.2748836","article-title":"Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings","volume":"172","author":"Mirowitz","year":"1989","journal-title":"Radiology"},{"key":"B204","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1148\/radiology.189.3.8234713","article-title":"Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging","volume":"189","author":"Oba","year":"1993","journal-title":"Radiology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/jmri.24121","article-title":"Brain iron MRI: a biomarker for amyotrophic lateral sclerosis","volume":"38","author":"Ignjatovic","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"B206","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jon.12127","article-title":"Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis","volume":"25","author":"Adachi","year":"2015","journal-title":"J Neuroimaging"},{"key":"B207","doi-asserted-by":"publisher","first-page":"e35241","DOI":"10.1371\/journal.pone.0035241","article-title":"Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology","volume":"7","author":"Kwan","year":"2012","journal-title":"PLoS ONE"},{"key":"B208","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00234-005-1421-5","article-title":"Cortical T2 signal shortening in amyotrophic lateral sclerosis is not due to iron deposits","volume":"47","author":"Hecht","year":"2005","journal-title":"Neuroradiology"},{"key":"B209","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/ane.12863","article-title":"Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis","volume":"137","author":"Vazquez-Costa","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"B210","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1007\/s00415-017-8728-0","article-title":"Low signal intensity in motor cortex on susceptibility-weighted MR imaging is correlated with clinical signs of amyotrophic lateral sclerosis: a pilot study","volume":"265","author":"Endo","year":"2018","journal-title":"J Neurol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/WNL.53.5.1051","article-title":"Diffusion tensor MRI assesses corticospinal tract damage in ALS","volume":"53","author":"Ellis","year":"1999","journal-title":"Neurology."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1212\/01.WNL.0000145766.03057.E7","article-title":"Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS","volume":"63","author":"Graham","year":"2004","journal-title":"Neurology."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1212\/WNL.0b013e3181fb84d1","article-title":"Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis","volume":"75","author":"Filippini","year":"2010","journal-title":"Neurology"},{"key":"B214","first-page":"8295","article-title":"Quantitative assessment of amyotrophic lateral sclerosis with diffusion tensor imaging in 3.0T magnetic resonance","volume":"8","author":"Tang","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"B215","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1148\/radiol.2393050573","article-title":"Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T","volume":"239","author":"Wang","year":"2006","journal-title":"Radiology."},{"key":"B216","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1212\/01.wnl.0000299186.72374.19","article-title":"Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation","volume":"70","author":"Iwata","year":"2008","journal-title":"Neurology"},{"key":"B217","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/hbm.20527","article-title":"Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics","volume":"30","author":"Ciccarelli","year":"2009","journal-title":"Hum Brain Mapping"},{"key":"B218","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.brainres.2010.05.067","article-title":"Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis","volume":"1348","author":"Metwalli","year":"2010","journal-title":"Brain Res"},{"key":"B219","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/jnnp.2006.100032","article-title":"Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis","volume":"78","author":"Valsasina","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B220","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neuroimage.2010.06.060","article-title":"Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis","volume":"53","author":"Nair","year":"2010","journal-title":"Neuroimage"},{"key":"B221","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/hbm.20364","article-title":"Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability","volume":"28","author":"Agosta","year":"2007","journal-title":"Hum Brain Mapping"},{"key":"B222","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1002\/hbm.20794","article-title":"Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited","volume":"30","author":"Sage","year":"2009","journal-title":"Hum Brain Mapping"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr016","article-title":"Upper and extra-Moto neuron involvement in early Moto neuron disease: a diffusion tensor imaging study","author":"van","year":"2011","journal-title":"Brain"},{"key":"B224","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3389\/fnhum.2017.00567","article-title":"Longitudinal diffusion tensor imaging-based assessment of tract alterations: an application to amyotrophic lateral sclerosis","volume":"11","author":"Baldaranov","year":"2017","journal-title":"Front Hum Neurosci"},{"key":"B225","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.acra.2013.03.017","article-title":"Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis","volume":"20","author":"Foerster","year":"2013","journal-title":"Acad Radiol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/jnnp-2017-316365","article-title":"Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker","volume":"89","author":"Kassubek","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B227","doi-asserted-by":"publisher","first-page":"e0167331","DOI":"10.1371\/journal.pone.0167331","article-title":"Development of an automated MRI-based diagnostic protocol for amyotrophic lateral sclerosis using disease-specific pathognomonic features: a quantitative disease-state classification study","volume":"11","author":"Schuster","year":"2016","journal-title":"PLoS ONE"},{"key":"B228","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.nicl.2017.08.002","article-title":"Multimodal structural MRI in the diagnosis of motor neuron diseases","volume":"16","author":"Ferraro","year":"2017","journal-title":"Neuroimage Clin"},{"key":"B229","first-page":"1541","article-title":"Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements","volume":"18","author":"Kato","year":"1997","journal-title":"Am J Neuroradiol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0730-725X(98)00129-5","article-title":"Reduced MTR in the corticospinal tract and normal T in Amyotrophic Lateral Sclerosis","volume":"16","author":"Tanabe","year":"1998","journal-title":"Magn Reson Imaging"},{"key":"B231","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3174\/ajnr.A2356","article-title":"Magnetization transfer imaging demonstrates a distributed pattern of microstructural changes of the cerebral cortex in amyotrophic lateral sclerosis","volume":"32","author":"Cosottini","year":"2011","journal-title":"Am J Neuroradiol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00221-001-0981-9","article-title":"Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study","volume":"143","author":"Konrad","year":"2002","journal-title":"Exp Brain Res"},{"key":"B233","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00415-005-0787-y","article-title":"Functional motor compensation in amyotrophic lateral sclerosis","volume":"252","author":"Schoenfeld","year":"2005","journal-title":"J Neurol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00221-006-0352-7","article-title":"Subcortical reorganization in amyotrophic lateral sclerosis","volume":"172","author":"Konrad","year":"2006","journal-title":"Exp Brain Res"},{"key":"B235","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s00415-006-0513-4","article-title":"Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways","volume":"254","author":"Stanton","year":"2007","journal-title":"J Neurol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/hbm.22070","article-title":"Brain plasticity in the motor network is correlated with disease progression in amyotrophic lateral sclerosis","volume":"34","author":"Poujois","year":"2013","journal-title":"Hum Brain Mapping"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00415-009-5112-8","article-title":"Decreased brain activation to tongue movements in amyotrophic lateral sclerosis with bulbar involvement but not Kennedy syndrome","volume":"256","author":"Mohammadi","year":"","journal-title":"J Neurol"},{"key":"B238","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1007\/s00415-010-5842-7","article-title":"Patterns of cortical activity differ in ALS patients with limb and\/or bulbar involvement depending on motor tasks","volume":"258","author":"Kollewe","year":"2011","journal-title":"J Neurol"},{"key":"B239","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/1545968307300698","article-title":"Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function","volume":"21","author":"Lule","year":"2007","journal-title":"Neurorehabil Neural Repair"},{"key":"B240","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2007.07.044","article-title":"Cortical activation during motor imagery is reduced in amyotrophic lateral sclerosis","volume":"1172","author":"Stanton","year":"2007","journal-title":"Brain Res"},{"key":"B241","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2009.01.025","article-title":"Changes of resting state brain networks in amyotrophic lateral sclerosis","volume":"217","author":"Mohammadi","year":"2009","journal-title":"Exp Neurol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1007\/s00415-011-6088-8","article-title":"Altered patterns of cortical activation in ALS patients during attention and cognitive response inhibition tasks","volume":"258","author":"Goldstein","year":"2011","journal-title":"J Neurol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00415-006-0409-3","article-title":"Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS)","volume":"254","author":"Lule","year":"2007","journal-title":"J Neurol"},{"key":"B244","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1007\/s00415-010-5640-2","article-title":"Right hemisphere dysfunction and emotional processing in ALS: an fMRI study","volume":"257","author":"Palmieri","year":"2010","journal-title":"J Neurol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/jnnp.2009.192260","article-title":"Neuroimaging of multimodal sensory stimulation in amyotrophic lateral sclerosis","volume":"81","author":"Lule","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B246","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/brain\/awh170","article-title":"Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study","volume":"127","author":"Abrahams","year":"2004","journal-title":"Brain"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/WNL.51.4.1104","article-title":"A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings","volume":"51","author":"Ellis","year":"1998","journal-title":"Neurology"},{"key":"B248","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/1522-2594(200103)45:3<513::AID-MRM1067>3.0.CO;2-D","article-title":"Reanalysis of multislice H MRSI in amyotrophic lateral sclerosis","volume":"45","author":"Schuff","year":"2001","journal-title":"Magn Reson Med"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/01.wnl.0000260065.57832.87","article-title":"Quantitative objective markers for upper and lower motor neuron dysfunction in ALS","volume":"68","author":"Mitsumoto","year":"2007","journal-title":"Neurology."},{"key":"B250","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0022-510X(95)00072-A","article-title":"Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis)","volume":"129","author":"Jones","year":"1995","journal-title":"J Neurol Sci"},{"key":"B251","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1212\/WNL.48.4.878","article-title":"Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy","volume":"48","author":"Gredal","year":"1997","journal-title":"Neurology"},{"key":"B252","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jmri.22053","article-title":"Study of the features of proton MR spectroscopy (H-MRS) on amyotrophic lateral sclerosis","volume":"31","author":"Han","year":"2010","journal-title":"J Magn Reson Imaging"},{"key":"B253","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00234-010-0685-6","article-title":"Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis","volume":"52","author":"Sivak","year":"2010","journal-title":"Neuroradiology"},{"key":"B254","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1212\/WNL.0b013e3182563b57","article-title":"Decreased motor cortex \u03b3-aminobutyric acid in amyotrophic lateral sclerosis","volume":"78","author":"Foerster","year":"2012","journal-title":"Neurology"},{"key":"B255","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2013.234","article-title":"An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy","volume":"70","author":"Foerster","year":"2013","journal-title":"JAMA Neurol"},{"key":"B256","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neulet.2014.04.020","article-title":"Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique","volume":"570","author":"Weiduschat","year":"2014","journal-title":"Neurosci Lett"},{"key":"B257","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jocn.2015.08.044","article-title":"The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis","volume":"27","author":"Sako","year":"2016","journal-title":"J Clin Neurosci"},{"key":"B258","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s11064-017-2248-2","article-title":"Ultra-High field proton MR spectroscopy in early-stage amyotrophic lateral sclerosis","volume":"42","author":"Cheong","year":"2017","journal-title":"Neurochem Res"},{"key":"B259","doi-asserted-by":"publisher","first-page":"e0177680","DOI":"10.1371\/journal.pone.0177680","article-title":"Ultra high-field (7tesla) magnetic resonance spectroscopy in amyotrophic lateral sclerosis","volume":"12","author":"Atassi","year":"2017","journal-title":"PLoS ONE"},{"key":"B260","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/08990220.2016.1275544","article-title":"Detecting neuronal dysfunction of hand motor cortex in ALS: a MRSI study","volume":"34","author":"Wang","year":"2017","journal-title":"Somatosens Mot Res"},{"key":"B261","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0022-510X(97)00244-X","article-title":"MR spectroscopy in amyotrophic lateral sclerosis\/motor neuron disease","volume":"152","author":"Pioro","year":"1997","journal-title":"J Neurol Sci"},{"key":"B262","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1212\/WNL.50.1.72","article-title":"Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy","volume":"50","author":"Cwik","year":"1998","journal-title":"Neurology"},{"key":"B263","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1212\/WNL.53.1.71","article-title":"1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla","volume":"53","author":"Pioro","year":"1999","journal-title":"Neurology"},{"key":"B264","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/17482968.2010.515223","article-title":"Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis","volume":"12","author":"Carew","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"B265","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mus.23467","article-title":"Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis","volume":"47","author":"Ikeda","year":"2013","journal-title":"Muscle Nerve"},{"key":"B266","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1148\/radiol.13121148","article-title":"Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging","volume":"267","author":"Verma","year":"2013","journal-title":"Radiology"},{"key":"B267","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/17482960902756473","article-title":"Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis","volume":"11","author":"Pyra","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"B268","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1148\/radiology.212.3.r99au35763","article-title":"Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain","volume":"212","author":"Chan","year":"1999","journal-title":"Radiology"},{"key":"B269","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejrad.2014.10.019","article-title":"The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis","volume":"84","author":"Cervo","year":"2015","journal-title":"Eur J Radiol"},{"key":"B270","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1212\/01.WNL.0000125182.17874.59","article-title":"Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS)","volume":"62","author":"Kaufmann","year":"2004","journal-title":"Neurology"},{"key":"B271","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/acn3.30","article-title":"Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis","volume":"1","author":"Foerster","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"B272","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00415-006-0495-2","article-title":"Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study","volume":"254","author":"Unrath","year":"2007","journal-title":"J Neurol."},{"key":"B273","first-page":"647","article-title":"MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis","volume":"21","author":"Bowen","year":"2000","journal-title":"Am J Neuroradiol"},{"key":"B274","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/14660820410017109","article-title":"Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study","volume":"5","author":"Rule","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"B275","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1097\/00001756-199806010-00016","article-title":"Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy","volume":"9","author":"Kalra","year":"1998","journal-title":"Neuroreport"},{"key":"B276","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00415-006-0162-7","article-title":"Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging","volume":"253","author":"Kalra","year":"2006","journal-title":"J Neurol"},{"key":"B277","first-page":"476","article-title":"Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy","volume":"24","author":"Kalra","year":"2003","journal-title":"Am J Neuroradiol"},{"key":"B278","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.mri.2010.06.032","article-title":"MRS study of the effects of minocycline on markers of neuronal and microglial integrity in ALS","volume":"28","author":"Khiat","year":"2010","journal-title":"Magn Reson Imaging."},{"key":"B279","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3109\/17482961003797130","article-title":"A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis","volume":"11","author":"Atassi","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"B280","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s00415-011-6146-2","article-title":"A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results","volume":"259","author":"Sacca","year":"2012","journal-title":"J Neurol"},{"key":"B281","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jcyt.2016.03.296","article-title":"Spinal cord infusion of stem cells in amyotrophic lateral sclerosis: magnetic resonance spectroscopy shows metabolite improvement in the precentral gyrus","volume":"18","author":"Garcia","year":"2016","journal-title":"Cytotherapy"},{"key":"B282","doi-asserted-by":"publisher","first-page":"e35607","DOI":"10.1371\/journal.pone.0035607","article-title":"Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy","volume":"7","author":"Govind","year":"2012","journal-title":"PLoS ONE"},{"key":"B283","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/mus.24630","article-title":"MRI abnormalities of peripheral nerve and muscle are common in amyotrophic lateral sclerosis and share features with multifocal motor neuropathy","volume":"52","author":"Staff","year":"2015","journal-title":"Muscle Nerve"},{"key":"B284","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/ana.410250508","article-title":"Amyotrophic lateral sclerosis: abnormalities of the tongue on magnetic resonance imaging","volume":"25","author":"Cha","year":"1989","journal-title":"Ann Neurol"},{"key":"B285","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-017-8443-x","article-title":"Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS","volume":"264","author":"Simon","year":"2017","journal-title":"J Neurol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1212\/WNL.51.1.110","article-title":"Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis","volume":"51","author":"Bryan","year":"1998","journal-title":"Neurology"},{"key":"B287","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1148\/radiol.2015150559","article-title":"MR Imaging of brachial plexus and limb-girdle muscles in patients with amyotrophic lateral sclerosis","volume":"279","author":"Gerevini","year":"2016","journal-title":"Radiology"},{"key":"B288","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/jnnp-2017-316744","article-title":"Imaging muscle as a potential biomarker of denervation in motor neuron disease","volume":"89","author":"Jenkins","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B289","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/mus.24223","article-title":"Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis","volume":"50","author":"Ryan","year":"2014","journal-title":"Muscle Nerve"},{"key":"B290","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/17482960600765065","article-title":"A prospective study to evaluate the impact of 31P-MRS to determinate mitochondrial dysfunction in skeletal muscle of ALS patients","volume":"8","author":"Grehl","year":"2007","journal-title":"Amyotroph Lateral Scler"},{"key":"B291","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/mrm.1910070402","article-title":"Metabolic changes in human muscle denervation: topical 31P NMR spectroscopy studies","volume":"7","author":"Zochodne","year":"1988","journal-title":"Magn Reson Med"},{"key":"B292","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1212\/WNL.45.4.733","article-title":"Physiology of fatigue in amyotrophic lateral sclerosis","volume":"45","author":"Sharma","year":"1995","journal-title":"Neurology"},{"key":"B293","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<909::AID-MUS10>3.0.CO;2-V","article-title":"Central fatigue during isometric exercise in amyotrophic lateral sclerosis","volume":"23","author":"Kent-Braun","year":"2000","journal-title":"Muscle Nerve"},{"key":"B294","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00004728-198807000-00019","article-title":"Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study","volume":"12","author":"Hatazawa","year":"1988","journal-title":"J Comput Assist Tomogr"},{"key":"B295","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.0000000000000792","article-title":"Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis","volume":"83","author":"Pagani","year":"2014","journal-title":"Neurology"},{"key":"B296","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1212\/WNL.0000000000002242","article-title":"18F-FDG-PET correlates of cognitive impairment in ALS","volume":"86","author":"Canosa","year":"2016","journal-title":"Neurology."},{"key":"B297","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2967\/jnumed.115.166272","article-title":"Prospective validation of 18F-FDG brain PET discriminant analysis methods in the diagnosis of amyotrophic lateral sclerosis","volume":"57","author":"Van","year":"2016","journal-title":"J Nucl Med"},{"key":"B298","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00259-011-1979-6","article-title":"Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset","volume":"39","author":"Cistaro","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2018.1476548.","article-title":"Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls","author":"D'hulst","year":"","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B300","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol Dis"},{"key":"B301","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nicl.2015.01.009","article-title":"Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [C]-PBR2(2016) 8","volume":"7","author":"Zurcher","year":"2015","journal-title":"Neuroimage Clin"},{"key":"B302","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1212\/WNL.0000000000003427","article-title":"Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis","volume":"87","author":"Alshikho","year":"2016","journal-title":"Neurology"},{"key":"B303","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.nicl.2018.08.007","article-title":"Integrated imaging of [C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy H-MRS in amyotrophic lateral sclerosis","volume":"20","author":"Ratai","year":"2018","journal-title":"NeuroImage Clin"},{"key":"B304","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1093\/brain\/123.11.2289","article-title":"Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil","volume":"123","author":"Lloyd","year":"2000","journal-title":"Brain"},{"key":"B305","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/brain\/awh509","article-title":"Distinct cerebral lesions in sporadic and \u2018D90A\u2019 SOD1 ALS: studies with [11C]flumazenil PET","volume":"128","author":"Turner","year":"2005","journal-title":"Brain."},{"key":"B306","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/brain\/awh428","article-title":"[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS","volume":"128","author":"Turner","year":"2005","journal-title":"Brain."},{"key":"B307","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1212\/WNL.0000000000001588","article-title":"Increased oxidative stress is related to disease severity in the ALS motor cortex. A PET study","volume":"84","author":"Ikawa","year":"2015","journal-title":"Neurology."},{"key":"B308","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1474-4422(11)70049-7","article-title":"Towards a neuroimaging biomarker for amyotrophic lateral sclerosis","volume":"10","author":"Turner","year":"","journal-title":"Lancet Neurol"},{"key":"B309","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/jnnp.34.2.121","article-title":"Electrophysiological estimation of the number of motor units within a human muscle","volume":"34","author":"McComas","year":"1971","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B310","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mus.24442","article-title":"Motor unit number estimation: a technology and literature review","volume":"50","author":"Gooch","year":"2014","journal-title":"Muscle Nerve"},{"key":"B311","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.clinph.2017.11.012","article-title":"Correlations between MUNIX and adapted multiple point stimulation MUNE methods","volume":"129","author":"Benmouna","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"B312","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.39.10.973","article-title":"Multiple point electrical stimulation of ulnar and median nerves","volume":"39","author":"Kadrie","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B313","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1212\/WNL.0b013e318225aabf","article-title":"Multipoint incremental motor unit number estimation as an outcome measure in ALS","volume":"77","author":"Shefner","year":"2011","journal-title":"Neurology."},{"key":"B314","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/WNL.49.2.573","article-title":"Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis","volume":"49","author":"Yuen","year":"1997","journal-title":"Neurology"},{"key":"B315","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1541-0420.2006.00577.x","article-title":"Motor unit number estimation\u2013a Bayesian approach","volume":"62","author":"Ridall","year":"2006","journal-title":"Biometrics"},{"key":"B316","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mus.21495","article-title":"Sensitivity of electrophysiological tests for upper and lower motor neuron dysfunction in ALS: a six-month longitudinal study","volume":"41","author":"de","year":"2010","journal-title":"Muscle Nerve"},{"key":"B317","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/jnnp.73.2.199","article-title":"Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation","volume":"73","author":"Aggarwal","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B318","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mus.20671","article-title":"Revised statistical motor unit number estimation in the Celecoxib\/ALS trial","volume":"35","author":"Shefner","year":"2007","journal-title":"Muscle Nerve"},{"key":"B319","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1016\/j.clinph.2016.03.024","article-title":"Lower motor neuron dysfunction in ALS","volume":"127","author":"de","year":"2016","journal-title":"Clin Neurophysiol."},{"key":"B320","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/mus.21680","article-title":"Monitoring disease progression using high-density motor unit number estimation in amyotrophic lateral sclerosis","volume":"42","author":"van","year":"2010","journal-title":"Muscle Nerve"},{"key":"B321","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mus.24945","article-title":"Estimating motor unit numbers from a CMAP scan","volume":"53","author":"Bostock","year":"2016","journal-title":"Muscle Nerve"},{"key":"B322","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/mus.26304","article-title":"Following disease progression in motor neuron disorders with 3 MUNE methods","volume":"59","author":"Jacobsen","year":"2018","journal-title":"Muscle Nerve"},{"key":"B323","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1109\/TBME.2004.834281","article-title":"Motor unit number index (MUNIX)","volume":"51","author":"Nandedkar","year":"2004","journal-title":"IEEE Trans Biomed Eng"},{"key":"B324","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.clinph.2011.02.017","article-title":"Motor Unit Number Index (MUNIX): a novel neurophysiological marker for neuromuscular disorders; test-retest reliability in healthy volunteers","volume":"122","author":"Neuwirth","year":"2011","journal-title":"Clin Neurophysiol"},{"key":"B325","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/jnnp-2015-310509","article-title":"Tracking motor neuron loss in a set of six muscles in amyotrophic lateral sclerosis using the Motor Unit Number Index (MUNIX): a 15-month longitudinal multicentre trial","volume":"86","author":"Neuwirth","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B326","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.clinph.2017.03.045","article-title":"Reproducibility, and sensitivity to motor unit loss in amyotrophic lateral sclerosis, of a novel MUNE method: MScanFit MUNE","volume":"128","author":"Jacobsen","year":"2017","journal-title":"Clin Neurophysiol."},{"key":"B327","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.clinph.2012.01.004","article-title":"Motor unit number index (MUNIX) versus motor unit number estimation (MUNE): a direct comparison in a longitudinal study of ALS patients","volume":"123","author":"Boekestein","year":"2012","journal-title":"Clin Neurophysiol"},{"key":"B328","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.clinph.2018.04.614","article-title":"Implementing Motor Unit Number Index (MUNIX) in a large clinical trial: real world experience from 27 centres","volume":"129","author":"Neuwirth","year":"2018","journal-title":"Clin Neurophysiol"},{"key":"B329","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/mus.26087","article-title":"Motor unit number index and neurophysiological index as candidate biomarkers of presymptomatic motor neuron loss in amyotrophic lateral sclerosis","volume":"58","author":"Escorcio-Bezerra","year":"2018","journal-title":"Muscle Nerve"},{"key":"B330","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.clinph.2016.11.026","article-title":"Motor Unit Number Index (MUNIX) detects motor neuron loss in pre-symptomatic muscles in Amyotrophic Lateral Sclerosis","volume":"128","author":"Neuwirth","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"B331","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/mus.25595","article-title":"Global motor unit number index sum score for assessing the loss of lower motor neurons in amyotrophic lateral sclerosis","volume":"56","author":"Grimaldi","year":"2017","journal-title":"Muscle Nerve"},{"key":"B332","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.clinph.2016.06.011","article-title":"MUNIX: reproducibility and clinical correlations in amyotrophic lateral sclerosis","volume":"127","author":"Escorcio-Bezerra","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"B333","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<344::AID-MUS5>3.0.CO;2-N","article-title":"Nerve conduction studies in amyotrophic lateral sclerosis","volume":"23","author":"de","year":"2000","journal-title":"Muscle Nerve"},{"key":"B334","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/17482968.2010.531742","article-title":"Neurophysiological index as a biomarker for ALS progression: validity of mixed effects models","volume":"12","author":"Cheah","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"B335","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1212\/01.WNL.0000162036.76024.AB","article-title":"Quantitating progression in ALS","volume":"64","author":"de","year":"2005","journal-title":"Neurology."},{"key":"B336","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jamaneurol.2015.1872","article-title":"Cortical function in asymptomatic carriers and patients with C9orf72 amyotrophic lateral sclerosis","volume":"72","author":"Geevasinga","year":"2015","journal-title":"JAMA Neurol"},{"key":"B337","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl172","article-title":"Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease","author":"Vucic","year":"2006","journal-title":"Brain"},{"key":"B338","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s13311-016-0492-9","article-title":"Axonal excitability in amyotrophic lateral sclerosis: axonal excitability in ALS","volume":"14","author":"Park","year":"2017","journal-title":"Neurotherapeutics."},{"key":"B339","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C","article-title":"Threshold tracking techniques in the study of human peripheral nerve","volume":"21","author":"Bostock","year":"1998","journal-title":"Muscle Nerve"},{"key":"B340","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.clinph.2013.02.117","article-title":"Increased variability of axonal excitability in amyotrophic lateral sclerosis","volume":"124","author":"Shibuta","year":"2013","journal-title":"Clin Neurophysiol"},{"key":"B341","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl024","article-title":"Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage","author":"Kanai","year":"2006","journal-title":"Brain"},{"key":"B342","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/jnnp.2009.183079","article-title":"Upregulation of persistent sodium conductances in familial ALS","volume":"81","author":"Vucic","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B343","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2004.074138","article-title":"Increased persistent Na(+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice","author":"Kuo","year":"2005","journal-title":"J Physiol"},{"key":"B344","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1749-6632.1991.tb17321.x","article-title":"Reverse operation of the Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian CNS white matter","volume":"639","author":"Stys","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"B345","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamaneurol.2014.2940","article-title":"Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis","volume":"72","author":"Geevasinga","year":"2015","journal-title":"JAMA Neurol"},{"key":"B346","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jns.2017.08.3779","article-title":"Increased motor axonal persistent sodium currents is associated with rapid regional spreading in amyotrophic lateral sclerosis","volume":"381","author":"Kanai","year":"2017","journal-title":"J Neurol Sci"},{"key":"B347","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/jnnp-2011-301782","article-title":"Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis","volume":"83","author":"Kanai","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B348","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mus.21362","article-title":"Electrical impedance myography: background, current state, and future directions","volume":"40","author":"Rutkove","year":"2009","journal-title":"Muscle Nerve"},{"key":"B349","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13311-016-0473-z","article-title":"Assessment of motor units in neuromuscular disease","volume":"14","author":"Henderson","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B350","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mus.24611","article-title":"Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: a multicenter study of reliability and validity","volume":"52","author":"Zaidman","year":"2015","journal-title":"Muscle Nerve"},{"key":"B351","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.clinph.2005.12.029","article-title":"Test-retest reproducibility of 50 kHz linear-electrical impedance myography","volume":"117","author":"Rutkove","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"B352","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/mus.24128","article-title":"Electrical impedance myography correlates with standard measures of ALS severity","volume":"49","author":"Rutkove","year":"2014","journal-title":"Muscle Nerve"},{"key":"B353","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/17482968.2012.688837","article-title":"Electrical impedance myography as a biomarker to assess ALS progression","volume":"13","author":"Rutkove","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"B354","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/mus.21115","article-title":"Discriminating neurogenic from myopathic disease via measurement of muscle anisotropy","volume":"39","author":"Garmirian","year":"2009","journal-title":"Muscle Nerve"},{"key":"B355","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13311-016-0491-x","article-title":"Electrical impedance myography and its applications in neuromuscular disorders","volume":"14","author":"Sanchez","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B356","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: a critical review","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"B357","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/mus.25375","article-title":"Optimizing electrical impedance myography of the tongue in amyotrophic lateral sclerosis","volume":"55","author":"McIlduff","year":"2017","journal-title":"Muscle Nerve"},{"key":"B358","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/mus.24565","article-title":"Electrical impedance myography in the evaluation of the tongue musculature in amyotrophic lateral sclerosis","volume":"52","author":"Shellikeri","year":"2015","journal-title":"Muscle Nerve"},{"key":"B359","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","article-title":"Electrodiagnostic criteria for diagnosis of ALS","volume":"119","author":"de Carvalho","year":"2008","journal-title":"Clin Neurophysiol."},{"key":"B360","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13311-016-0487-6","article-title":"Transcranial magnetic stimulation for the assessment of neurodegenerative disease","volume":"14","author":"Vucic","year":"2017","journal-title":"Neurotherapeutics"},{"key":"B361","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(85)92413-4","article-title":"Non-invasive magnetic stimulation of human motor cortex","volume":"1","author":"Barker","year":"1985","journal-title":"Lancet"},{"key":"B362","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/jnnp-2012-304019","article-title":"Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights","volume":"84","author":"Vucic","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B363","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn071","article-title":"Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis","author":"Vucic","year":"2008","journal-title":"Brain"},{"key":"B364","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S1474-4422(15)00014-9","article-title":"Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study","volume":"14","author":"Menon","year":"2015","journal-title":"Lancet Neurol"},{"key":"B365","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/ene.13295","article-title":"Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis","volume":"24","author":"Menon","year":"2017","journal-title":"Eur J Neurol"},{"key":"B366","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.clinph.2010.12.062","article-title":"Cortical excitability distinguishes ALS from mimic disorders","volume":"122","author":"Vucic","year":"2011","journal-title":"Clin Neurophysiol"},{"key":"B367","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/01.wnl.0000341933.97883.a4","article-title":"Transcranial magnetic stimulation in ALS: utility of central motor conduction tests","volume":"72","author":"Floyd","year":"2009","journal-title":"Neurology"},{"key":"B368","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg260","article-title":"The natural history of central motor abnormalities in amyotrophic lateral sclerosis","author":"Mills","year":"2003","journal-title":"Brain"},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt085","article-title":"Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis","author":"Vucic","year":"2013","journal-title":"Brain"},{"key":"B370","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1155\/2004\/214152","article-title":"Statistical considerations in combining biomarkers for disease classification","volume":"20","author":"Feng","year":"2004","journal-title":"Dis Mark"},{"key":"B371","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nbt.3051","article-title":"Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression","volume":"33","author":"Kuffner","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B372","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/21678421.2013.838970","article-title":"Amyotrophic lateral sclerosis disease progression model","volume":"15","author":"Gomeni","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B373","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/21678421.2015.1083585","article-title":"Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): a simple scoring system for early prediction of patient survival","volume":"17","author":"Lunetta","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"B374","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mus.24979","article-title":"ALS biomarkers for therapy development: state of the field and future directions","volume":"53","author":"Benatar","year":"2016","journal-title":"Muscle Nerve"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T10:57:25Z","timestamp":1721127445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":374,"alternative-id":["10.3389\/fneur.2019.00291"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00291","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"article-number":"291"}}